Jasper Therapeutics, Inc.
NASDAQ:JSPR
23.87 (USD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -64.465 | -37.685 | -30.637 | -31.669 | -4.987 |
| Depreciation & Amortization
| 1.108 | 0.975 | 0.377 | 0.021 | 0 |
| Deferred Income Tax
| -4.383 | 0 | 3.001 | -0.021 | 0 |
| Stock Based Compensation
| 5.211 | 4.091 | 1.048 | 1.21 | 0.006 |
| Change In Working Capital
| 5.103 | -0.649 | 1.621 | 1.296 | 1.392 |
| Accounts Receivables
| 0.663 | -0.663 | 0.6 | 0 | 0 |
| Inventory
| 0 | 0.663 | -0.6 | 0 | 0 |
| Accounts Payables
| 2.381 | -2.151 | 2.938 | 0.358 | 0 |
| Other Working Capital
| 2.059 | 1.502 | -1.317 | 0.938 | 1.392 |
| Other Non Cash Items
| 5.359 | -12.59 | -9.088 | 10.896 | 1.62 |
| Operating Cash Flow
| -52.067 | -45.858 | -33.678 | -18.267 | -1.969 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -0.267 | -0.576 | -2.428 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0.198 | 0 |
| Investing Cash Flow
| -0.267 | -0.576 | -2.428 | 0.198 | 0 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 1.5 |
| Common Stock Issued
| 101.479 | 0.055 | 10.75 | 11.287 | 0 |
| Common Stock Repurchased
| 0 | 0.028 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.508 | 0.055 | 100.969 | 11.287 | 27.628 |
| Financing Cash Flow
| 100.971 | 0.055 | 100.969 | 11.287 | 29.128 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | -0.198 | 0 |
| Net Change In Cash
| 48.637 | -46.379 | 64.863 | -6.98 | 27.163 |
| Cash At End Of Period
| 86.887 | 38.667 | 85.046 | 20.183 | 27.163 |